A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.
Clinical trial NCT07032272 · COMPLETED
Trial details
- NCT number
- NCT07032272
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-23
- Primary completion
- 2025-10-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.